Browsing Tag
Vertex Pharmaceuticals Incorporated
1 post
Vertex Pharmaceuticals revenue reaches $3.44bn as $9bn Crinetics deal cuts profit and raises pipeline stakes
Vertex Pharmaceuticals reported 12% revenue growth and raised its annual sales guidance as cystic fibrosis treatments remained strong. However, acquisition-related expenses reduced statutory earnings, while the company's expansion into rare endocrine disorders and kidney disease introduces substantial clinical and commercial risks.